chr7-91079467-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001287135.2(CDK14):āc.1141C>Gā(p.Gln381Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000175 in 1,601,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 33)
Exomes š: 0.000017 ( 0 hom. )
Consequence
CDK14
NM_001287135.2 missense
NM_001287135.2 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 5.17
Genes affected
CDK14 (HGNC:8883): (cyclin dependent kinase 14) Enables cyclin binding activity and cyclin-dependent protein serine/threonine kinase activity. Involved in G2/M transition of mitotic cell cycle and regulation of canonical Wnt signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane. Part of cytoplasmic cyclin-dependent protein kinase holoenzyme complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.35497707).
BS2
High AC in GnomAdExome4 at 24 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK14 | NM_001287135.2 | c.1141C>G | p.Gln381Glu | missense_variant | 12/15 | ENST00000380050.8 | NP_001274064.1 | |
CDK14 | NM_012395.3 | c.1087C>G | p.Gln363Glu | missense_variant | 11/14 | NP_036527.1 | ||
CDK14 | NM_001287136.1 | c.1003C>G | p.Gln335Glu | missense_variant | 11/14 | NP_001274065.1 | ||
CDK14 | NM_001287137.1 | c.754C>G | p.Gln252Glu | missense_variant | 10/13 | NP_001274066.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK14 | ENST00000380050.8 | c.1141C>G | p.Gln381Glu | missense_variant | 12/15 | 1 | NM_001287135.2 | ENSP00000369390 | P4 | |
CDK14 | ENST00000265741.7 | c.1087C>G | p.Gln363Glu | missense_variant | 11/14 | 1 | ENSP00000265741 | |||
CDK14 | ENST00000406263.5 | c.1003C>G | p.Gln335Glu | missense_variant | 11/14 | 1 | ENSP00000385034 | A1 | ||
CDK14 | ENST00000436577.3 | c.754C>G | p.Gln252Glu | missense_variant | 10/13 | 2 | ENSP00000398936 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
152180
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248646Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134402
GnomAD3 exomes
AF:
AC:
2
AN:
248646
Hom.:
AF XY:
AC XY:
1
AN XY:
134402
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000166 AC: 24AN: 1449170Hom.: 0 Cov.: 26 AF XY: 0.0000166 AC XY: 12AN XY: 721562
GnomAD4 exome
AF:
AC:
24
AN:
1449170
Hom.:
Cov.:
26
AF XY:
AC XY:
12
AN XY:
721562
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360
GnomAD4 genome
AF:
AC:
4
AN:
152180
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2023 | The c.1087C>G (p.Q363E) alteration is located in exon 11 (coding exon 11) of the CDK14 gene. This alteration results from a C to G substitution at nucleotide position 1087, causing the glutamine (Q) at amino acid position 363 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;.;.;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
P;B;.;P
Vest4
MutPred
Loss of MoRF binding (P = 0.0373);.;.;.;
MVP
MPC
0.39
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at